Coya Therapeutics

COYANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$114.709 M

$4.89 +2.73%

Close of 18 Sept 2026

Revenue

$7.95M

#3199 by revenue

Earnings

-$21.2M

Loss-making

Shares outstanding

23,457,849

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#300Quantum CyberQUCY$116.0M
#301Tiziana Life SciencesTLSA$115.2M
#302Coya TherapeuticsCOYA$114.7M
#303GeneluxGNLX$114.5M
#304Milestone PharmaceuticalsMIST$114.0M

What if Coya Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.4T

$1,295,407

Per share 264,909× higher

Bitcoin $1.64T

$69,743.30

Per share 14,262× higher

Nvidia $5.36T

$228,354.57

Per share 46,698× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Coya Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.